A new type of collaboration is emerging in biotechnology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
de Taxis du Poet, P., Vassarotti, A., and Baselga de Elorz., J. (Eds.). 1995. “Biotechnology—Progress Report 1992-1994” Vol. 1. The European Commission, Brussels, Belgium.
Peale, M. 1994. Diversity Biotechnology Consortium: Searches for irrational cures. Bull. Santa Fe Inst. 9: 18–20.
O'Brian, C. 1994. Networking gene therapy. Science 266: 1151.
Glazer, V. 1995. Pfizer creates genomics consortium, Pfizergen. Bio/Technology 13: 534–535.
Lee, K.B. Jr., and Burrill, S.G. 1995. Biotech 96: Pursuing Sustainability. The Tenth Industry Annual Report. Ernst & Young LLP, London.
Bullock, W.O. and Dibner, M.D. 1995. The state of the US biotechnology industry. Trends Biotechnol. 13: 723–728.
Persidis, A. 1996. Building molecular value. J. Business Strat. 17: 18–20.
Persidis, A. 1995. Enabling technologies and the business of science. Bio/Technology 13: 1172–1176.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Persidis, A., Persidis, A. Biotechnology consortia versus multifirm alliances: Paradigm shift at work?. Nat Biotechnol 14, 1657–1660 (1996). https://doi.org/10.1038/nbt1296-1657
Issue Date:
DOI: https://doi.org/10.1038/nbt1296-1657
This article is cited by
-
Combinatorial chemistry
Nature Biotechnology (1997)